GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with type 2 diabetes.

US President Donald Trump’s recent weight loss has become the talk of the town after his recent medical exam revealed a ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

But, like all medications, there are side effects to using both Ozempic and Mounjaro with several celebrities sharing their ...

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...

GP leaders will vote on demanding payment for any additional work transferred to general practice from secondary care.

A study presented at ACC 2025 found that colchicine use in diabetic patients without CAD significantly reduced 3-year ...